As of April 15, 2025, Almirall (ALM.MC) has a market cap of $2.27 billion USD. According to our data, Almirall is ranked No.3792 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $2.27 B |
14.15%
|
Dec 31, 2024 | $1.98 B |
-0.33%
|
Dec 29, 2023 | $1.99 B |
-4.84%
|
Dec 30, 2022 | $2.09 B |
-18.56%
|
Dec 30, 2021 | $2.57 B |
4.82%
|
Dec 31, 2020 | $2.45 B |
-23.88%
|
Dec 31, 2019 | $3.22 B |
10.90%
|
Dec 31, 2018 | $2.90 B |
62.80%
|
Dec 29, 2017 | $1.78 B |
-42.73%
|
Dec 30, 2016 | $3.12 B |
-19.69%
|
Dec 31, 2015 | $3.88 B |
36.95%
|
Dec 31, 2014 | $2.83 B |
16.13%
|
Dec 31, 2013 | $2.44 B |
61.49%
|
Dec 31, 2012 | $1.51 B |
44.27%
|
Dec 30, 2011 | $1.05 B |
-19.29%
|
Dec 30, 2010 | $1.30 B |
-21.67%
|
Dec 30, 2009 | $1.66 B |
72.52%
|
Dec 30, 2008 | $0.96 B |
-62.64%
|
Dec 28, 2007 | $2.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
Market Cap | = | ALM.MC Stock Price | * | ALM.MC Shares Outstanding |
= | $10.63 | * | 0.21 B | |
= | $2.27 B |